L-glutamine combined with chemotherapy produced a 44% response rate in [...]
The FDA has granted Fast Track designation to Erasca’s investigational [...]
Elicio Therapeutics has reported that its Phase 2 Amplify-7P trial [...]
L-glutamine combined with chemotherapy produced a 44% response rate in [...]
The FDA has granted Fast Track designation to Erasca’s investigational [...]
Elicio Therapeutics has reported that its Phase 2 Amplify-7P trial [...]